{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:47:43Z","timestamp":1790819263280,"version":"4.1.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Research Foundation\u2014Flanders","award":["12I6319N"],"award-info":[{"award-number":["12I6319N"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To assess the impact of gestational antibiotics on the risk of preterm birth, since a healthy maternal microbiome may be protective.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Population-based cohort study including all first pregnancies in Sweden (2006\u201316). The association between gestational and recent pre-conception systemic antibiotics and preterm birth was assessed by multivariable logistic regression presented as ORs and 95% CIs, adjusted for comorbidities (hypo- and hyperthyroidism, hypertension, or diabetes mellitus pre-gestation), trimester, antibiotic class and treatment duration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared with non-users, antibiotic exposure was associated with increased risks of preterm birth in mothers with comorbidities (OR = 1.32, 95% CI 1.18\u20131.48) and without (OR = 1.09, 95% CI 1.06\u20131.13). Pre-conception use showed no association, while risk was increased for first and second trimester use and decreased for third trimester use. The increased risks were seen for the following antibiotic groups in mothers without and with comorbidities, respectively: macrolides, lincosamides and streptogramins (OR = 1.63, 95% CI 1.45\u20131.83; OR = 2.48, 95% CI 1.72\u20133.56); quinolones (OR = 1.60, 95% CI 1.32\u20131.94; OR = 2.11, 95% CI 1.12\u20134.03); non-penicillin \u03b2-lactams (OR = 1.15, 95% CI 1.07\u20131.24; OR = 1.39, 95% CI 1.07\u20131.83); other antibacterials (OR = 1.09, 95% CI 1.03\u20131.14; 1.38, 95% CI 1.16\u20131.63); and penicillins (OR = 1.04, 95% CI 1.01\u20131.08; 1.23, 95% CI 1.09\u20131.40). Antibiotic indications were not available, which could also affect preterm birth.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Antibiotic use during pregnancy was associated with an increased risk of preterm birth, especially in mothers with chronic diseases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkac053","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T20:13:15Z","timestamp":1644869595000},"page":"1461-1467","source":"Crossref","is-referenced-by-count":33,"title":["Antibiotic use during pregnancy and the risk of preterm birth: a population-based Swedish cohort study"],"prefix":"10.1093","volume":"77","author":[{"given":"M H","family":"Nguyen","sequence":"first","affiliation":[{"name":"I-BioStat, Data Science Institute, Hasselt University, Hasselt, Belgium"},{"name":"Centre for Translational Microbiome Research, Department of Microbiology Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Fornes","sequence":"additional","affiliation":[{"name":"Centre for Translational Microbiome Research, Department of Microbiology Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kamau","sequence":"additional","affiliation":[{"name":"I-BioStat, Data Science Institute, Hasselt University, Hasselt, Belgium"},{"name":"Centre for Translational Microbiome Research, Department of Microbiology Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Danielsson","sequence":"additional","affiliation":[{"name":"Centre for Translational Microbiome Research, Department of Microbiology Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden"},{"name":"Sach\u2019s Children\u2019s and Youth Hospital, S\u00f6dersjukhuset, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Callens","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Fransson","sequence":"additional","affiliation":[{"name":"Centre for Translational Microbiome Research, Department of Microbiology Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Engstrand","sequence":"additional","affiliation":[{"name":"Centre for Translational Microbiome Research, Department of Microbiology Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bruyndonckx","sequence":"additional","affiliation":[{"name":"I-BioStat, Data Science Institute, Hasselt University, Hasselt, Belgium"},{"name":"Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0137-447X","authenticated-orcid":false,"given":"N.","family":"Brusselaers","sequence":"additional","affiliation":[{"name":"Centre for Translational Microbiome Research, Department of Microbiology Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden"},{"name":"Global Health Institute, Antwerp University, Antwerp, Belgium"},{"name":"Department of Head and Skin, Ghent University, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"key":"2022042812402757500_dkac053-B1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ijgo.13195","article-title":"Global burden of preterm birth","volume":"150","author":"Walani","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"2022042812402757500_dkac053-B2","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","article-title":"Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"issue":"Suppl 1","key":"2022042812402757500_dkac053-B3","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon: the global epidemiology of 15 million preterm births","volume":"10","author":"Blencowe","year":"2013","journal-title":"Reprod Health"},{"key":"2022042812402757500_dkac053-B4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"2022042812402757500_dkac053-B5","doi-asserted-by":"crossref","first-page":"7218187","DOI":"10.1155\/2018\/7218187","article-title":"The microbiome and preterm birth: A change in paradigm with profound implications for pathophysiologic concepts and novel therapeutic strategies","volume":"2018","author":"Staude","year":"2018","journal-title":"Biomed Res Int"},{"key":"2022042812402757500_dkac053-B6","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/s41591-019-0450-2","article-title":"The vaginal microbiome and preterm birth","volume":"25","author":"Fettweis","year":"2019","journal-title":"Nat Med"},{"key":"2022042812402757500_dkac053-B7","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1051\/medsci\/2018205","article-title":"[Spontaneous preterm birth and the maternal microbiome]","volume":"34","author":"C\u00f4t\u00e9","year":"2018","journal-title":"Med Sci (Paris)"},{"key":"2022042812402757500_dkac053-B8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.gtc.2019.04.002","article-title":"Prescribed drugs and the microbiome","volume":"48","author":"Brusselaers","year":"2019","journal-title":"Gastroenterol Clin North Am"},{"key":"2022042812402757500_dkac053-B9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap8914","article-title":"Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome","volume":"10","author":"Vich Vila","year":"2018","journal-title":"Sci Transl Med"},{"key":"2022042812402757500_dkac053-B10","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1111\/bcp.13364","article-title":"Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study","volume":"83","author":"Muanda","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"2022042812402757500_dkac053-B11","doi-asserted-by":"crossref","first-page":"E625","DOI":"10.1503\/cmaj.161020","article-title":"Use of antibiotics during pregnancy and risk of spontaneous abortion","volume":"189","author":"Muanda","year":"2017","journal-title":"CMAJ"},{"key":"2022042812402757500_dkac053-B12","first-page":"323","article-title":"Continuous low-dose antibiotics and cerclage for recurrent second-trimester pregnancy loss","volume":"45","author":"Shiffman","year":"2000","journal-title":"J Reprod Med"},{"key":"2022042812402757500_dkac053-B13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM200002243420802","article-title":"Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"342","author":"Carey","year":"2000","journal-title":"N Engl J Med"},{"key":"2022042812402757500_dkac053-B14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMoa003329","article-title":"Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection","volume":"345","author":"Klebanoff","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"2022042812402757500_dkac053-B15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1471-0528.2005.00589.x","article-title":"Can antibiotics prevent preterm birth\u2014the pro and con debate","volume":"112","author":"Lamont","year":"2005","journal-title":"BJOG"},{"key":"2022042812402757500_dkac053-B16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12958-022-00905-6","article-title":"Pregnancy, perinatal and childhood outcomes in women with and without Polycystic Ovary Syndrome and metformin during pregnancy: a nationwide population-based study","volume":"20","author":"Fornes","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"2022042812402757500_dkac053-B17","article-title":"The Swedish Medical Birth Registry - Statistics Sweden"},{"key":"2022042812402757500_dkac053-B18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022042812402757500_dkac053-B19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"2022042812402757500_dkac053-B20","article-title":"WHO \u2013 Collaborating Centre for Drug Statistics Methodology"},{"key":"2022042812402757500_dkac053-B21","doi-asserted-by":"crossref","DOI":"10.1002\/9781118548387","volume-title":"Applied Logistic Regression","author":"Hosmer","year":"2013"},{"key":"2022042812402757500_dkac053-B22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.0006-341X.2001.00120.x","article-title":"Akaike\u2019s information criterion in generalized estimating equations","volume":"57","author":"Pan","year":"2001","journal-title":"Biometrics"},{"key":"2022042812402757500_dkac053-B23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/CLEP.S16305","article-title":"Drug use during pregnancy in Sweden - assessed by the Prescribed Drug Register and the Medical Birth Register","volume":"3","author":"Stephansson","year":"2011","journal-title":"Clin Epidemiol"},{"issue":"Suppl 6","key":"2022042812402757500_dkac053-B24","first-page":"vi13","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009)","volume":"66","author":"Adriaenssens","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2022042812402757500_dkac053-B25","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/phar.1649","article-title":"A review of antibiotic use in pregnancy","volume":"35","author":"Bookstaver","year":"2015","journal-title":"Pharmacotherapy"},{"key":"2022042812402757500_dkac053-B26","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/jac\/dku063","article-title":"Measuring trends of outpatient antibiotic use in Europe: jointly modelling longitudinal data in defined daily doses and packages","volume":"69","author":"Bruyndonckx","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"2022042812402757500_dkac053-B27","doi-asserted-by":"crossref","first-page":"ii68","DOI":"10.1093\/jac\/dkab179","article-title":"Change-points in antibiotic consumption in the community, European Union\/European Economic Area, 1997-2017","volume":"76","author":"Bruyndonckx","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2022042812402757500_dkac053-B28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/14767050600965882","article-title":"Epidemiology of preterm birth and its clinical subtypes","volume":"19","author":"Ananth","year":"2006","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2022042812402757500_dkac053-B29","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/aje\/kwn202","article-title":"Pregnancy disorders that lead to delivery before the 28th week of gestation: an epidemiologic approach to classification","volume":"168","author":"McElrath","year":"2008","journal-title":"Am J Epidemiol"},{"key":"2022042812402757500_dkac053-B30","article-title":"The risk of preterm birth in low risk pregnant women with urinary tract infections","author":"Werter","year":"2021","journal-title":"Am J Perinatol"},{"key":"2022042812402757500_dkac053-B31","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s10096-006-0190-3","article-title":"Preterm birth due to maternal infection: Causative pathogens and modes of prevention","volume":"25","author":"Pararas","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2022042812402757500_dkac053-B32","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJM199512283332604","article-title":"Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group","volume":"333","author":"Hillier","year":"1995","journal-title":"N Engl J Med"},{"key":"2022042812402757500_dkac053-B33","first-page":"173","article-title":"Bacterial vaginosis in early pregnancy and pregnancy outcome","volume":"80","author":"Kurki","year":"1992","journal-title":"Obstet Gynecol"},{"key":"2022042812402757500_dkac053-B34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-2000-13448","article-title":"Infection and preterm birth","volume":"17","author":"Andrews","year":"2000","journal-title":"Am J Perinatol"},{"key":"2022042812402757500_dkac053-B35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ijgo.12829","article-title":"Treatment of bacterial vaginosis before 28 weeks of pregnancy to reduce the incidence of preterm labor","volume":"146","author":"Reboucas","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"2022042812402757500_dkac053-B36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.placenta.2019.03.011","article-title":"The influence of the vaginal microbiota on preterm birth: A systematic review and recommendations for a minimum dataset for future research","volume":"79","author":"Peelen","year":"2019","journal-title":"Placenta"},{"key":"2022042812402757500_dkac053-B37","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fmicb.2020.00476","article-title":"Meta-analysis of vaginal microbiome data provides new insights into preterm birth","volume":"11","author":"Kosti","year":"2020","journal-title":"Front Microbiol"},{"key":"2022042812402757500_dkac053-B38","first-page":"CD000262","article-title":"Antibiotics for treating bacterial vaginosis in pregnancy","author":"McDonald","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2022042812402757500_dkac053-B39","doi-asserted-by":"crossref","first-page":"e00797-20","DOI":"10.1128\/mBio.00797-20","article-title":"Intra-amniotic infection with Ureaplasma parvum causes preterm birth and neonatal mortality that are prevented by treatment with clarithromycin","volume":"11","author":"Motomura","year":"2020","journal-title":"mBio"},{"key":"2022042812402757500_dkac053-B40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejogrb.2020.05.027","article-title":"Factors associated with preterm birth in women undergoing cervical cerclage","volume":"251","author":"Kunpalin","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2022042812402757500_dkac053-B41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3410\/M1-22","article-title":"The role of antibiotics in the prevention of preterm birth","volume":"1","author":"Bowes","year":"2009","journal-title":"F1000 Med Rep"},{"key":"2022042812402757500_dkac053-B42","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1479-828X.2007.00759.x","article-title":"Prophylactic antibiotics for the prevention of preterm birth in women at risk: a meta-analysis","volume":"47","author":"Simcox","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2022042812402757500_dkac053-B43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11095-018-2383-8","article-title":"Pregnancy outcomes following exposure to quinolone antibiotics \u2013 a systematic-review and meta-analysis","volume":"35","author":"Ziv","year":"2018","journal-title":"Pharm Res"},{"key":"2022042812402757500_dkac053-B44","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/1471-0528.15119","article-title":"The safety of quinolones and fluoroquinolones in pregnancy: a meta-analysis","volume":"125","author":"Yefet","year":"2018","journal-title":"BJOG"},{"key":"2022042812402757500_dkac053-B45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1701-2163(16)32350-7","article-title":"The effect of second-trimester antibiotic therapy on the rate of preterm birth","volume":"29","author":"Morency","year":"2007","journal-title":"J Obstet Gynaecol Can"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/5\/1461\/43480613\/dkac053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/5\/1461\/43480613\/dkac053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T12:44:09Z","timestamp":1651149849000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/77\/5\/1461\/6540605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,3,2]]},"published-print":{"date-parts":[[2022,4,27]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkac053","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5,1]]},"published":{"date-parts":[[2022,3,2]]}}}